Manvinder Singh
Dr. Singh’s clinical focus is on female and male infertility, recurrent pregnancy loss, reproductive surgery, ovulation problems, diminished ovarian reserve and congenital utero-vaginal anomalies.
Dr. Singh’s clinical focus is on female and male infertility, recurrent pregnancy loss, reproductive surgery, ovulation problems, diminished ovarian reserve and congenital utero-vaginal anomalies.
Manvinder Singh, MD, is Program Director, Reproductive Endocrinology and Infertility and Associate Professor at Montefiore-Einstein. Dr. Singh’s clinical focus is on female and male infertility, recurrent pregnancy loss, reproductive surgery, ovulation problems, diminished ovarian reserve and congenital utero-vaginal anomalies.<br /><br />In 1982, Dr. Singh received his Bachelor of Arts from New York University. He went on to attend New York Medical College, earning his Doctor of Medicine in 1987. His postdoctoral training began at Maimonides Medical Center with a residency in obstetrics and gynecology, which he completed in 1991. He then pursued a yearlong reproductive surgery fellowship at Union Memorial Hospital, which he completed in 1992. He continued his training at University of Louisville School of Medicine, completing a reproductive endocrinology and infertility fellowship in 1994.<br /><br />Dr. Singh has clinical research interests in in-vitro fertilization, infertility and reproductive endocrinology. He has shared his work in many peer-reviewed journals, book chapters and abstracts as well as at invited presentations.<br /><br />Dr. Singh is board certified in general obstetrics and gynecology as well as reproductive endocrinology and infertility. He is a member of several professional societies, including the American Society of Reproductive Medicine, the Society of Reproductive Endocrinology and Infertility and the Society of Assisted Reproductive Technology.<br /><p style="line-height:115%;"></p>
Staci E. Pollack
<p>Dr. Pollack treats patients with infertility, recurrent pregnancy loss, adolescent/pediatric gynecology issues, menopause, premature ovarian failure and other reproductive endocrine issues at Montefiore’s Institute for Reproductive Medicine & Health in Hartsdale, NY. At this state of the art IVF center, she performs all assisted reproductive technology treatments. . According to CDC data for 2012, 1.5 percent of babies born in the US are conceived by IVF, and this number is expected to increase. Women have a wide range of issues, including problems with ovulation, tubal infertility, endometriosis and congenital abnormalities of the reproductive tract.</p>
Infertility, Polycystic Ovary Syndrome (PCOS), Primary Ovarian Insufficiency (POI), in vitro Fertilization (IVF), Preimplantation Genetic Testing (PGT), Fertility Preservation, Third-Party Reproduction (including oocyte, sperm, and embryo donation), Reproductive Anomalies, Turner Syndrome, Congenital Adrenal Hyperplasia, Surgery to repair the uterus and fallopian tubes, Pediatric/Adolescent Gynecology<br />Research
Dr. Pollack's research interests include medical education and fertility treatment outcome studies. Her most recent studies have used the annual Society for Assisted Reproductive Technology (SART) clinical summary report to assess various IVF treatments and results at a national level.
<p>Staci E. Pollack, MD, MS, is the Director of Undergraduate Medical Education for the Department of Obstetrics and Gynecolgy & Women’s Health and an Associate Professor at Montefiore-Einstein. A large portion of her time is towards educating the next generation of doctors, as the OBGYN Clerkship Director, Acting Internship/Electives Director and Reproductive Systems and Human Sexuality Course Director. Dr. Pollack’s clinical focus is on reproductive endocrinology, infertility, fertility preservation, pediatric and adolescent gynecology, reproductive anomalies, recurrent pregnancy loss, Turner syndrome, primary ovarian insufficiency and genetic conditions causing menstrual irregularities or infertility, including Kallmann syndrome.</p><p>After earning her Bachelor of Arts in biology and genetics at Cornell University College of Arts & Sciences in 1987, Dr. Pollack attended State University of New York at Buffalo, earning her Master of Science in natural sciences and biology in 1988. She then pursued her Doctor of Medicine at State University of New York Health Science Center at Brooklyn-Downstate, earning her degree in 1992. She started her postdoctoral training with a four-year internship and residency in obstetrics and gynecology at Yale-New Haven Hospital, which she completed in 1996. Following this, she pursued a two-year fellowship in reproductive endocrinology and infertility at the Hospital of the University of Pennsylvania, completing it in 1998.</p><p>Dr. Pollack’s research is related to fertility treatments and medical education research. She has shared her work in several peer-reviewed journals, book chapters and abstracts, as well as through many invited presentations nationally. Dr. Pollack is also an ad hoc reviewer for several journals including Fertility and Sterility, the American Journal of Medical Genetics and Maturitas.</p><p>Dr. Pollack is board certified in both Obstetrics and Gynecology and Reproductive Endocrinology & Infertility. She is an active member of the American Society for Reproductive Medicine, the American Board of Obstetrics and Gynecology, the North American Society for Pediatric and Adolescent Gynecology, and the Association of Professors of Gynecology & Obstetrics, serving on many national committees for these organizations. She has been recognized several times for her training and mentorship, including receiving the Leo M. Davidoff Society Award for outstanding achievement in the teaching of medical students in 2003 and the American Society for Reproductive Medicine Service Award in 2017.</p>
Sophia N. Palmer
<p>Minimally Invasive Gynecologic Surgery</p>
<p>Advanced Gynecologic Ultrasound</p>
<p>Individualized, Patient-Centered Care</p>
<p>Uterine Fibroids, Adenomyosis, Endometriosis, Abnormal Uterine Bleeding, Pelvic Pain, Myofascial Pain, Endometrial polyps, Abnormal PAP Smears, Cervical Dysplasia, Polycystic Ovarian Syndrome (PCOS), Infertiilty, Vulvar disorders.</p>
<p> </p>
<p><span style="text-decoration: underline;"><strong>Publications and Abstracts </strong></span></p>
<p><strong>Palmer S</strong>, Greenburg JA. Transcervical sterilization: A comparison of Essure permanent birth control system and Adiana permanent contraception system. Rev Obstet Gynecol. 2009 Spring;2(2):84-92.</p>
<p><strong>Palmer S</strong>, Chudnoff S, Levie M. Knowledge of Basic Electrosurgical Principles: A Survey of Surgeons Albert Einstein College of Medicine, Resident Research Day June 2008</p>
<p>AAGL 38th Global Congress of Minimally Invasive Gynecology Nov 2009 Levie M, Chudnoff S, <strong>Palmer S</strong>. Hysteroscopic Placement of Essure Device in an Office Setting: A Critical Analysis</p>
<p>AAGL 37th Global Congress of Minimally Invasive Gynecology Nov 2008 Blackwood A, Young M, Schuchter L , Guerry D, Dhulipala R , <strong>Palmer S</strong>, Ganguly A. Multiple Primary Melanoma, Family History, and Germline Mutations in CDKN2A. 1999 ASCO Annual Meeting</p>
Harry J. Lieman
<p>Areas of interest:</p>
<p>Polycystic Ovary Syndrome (PCOS),<em> in vitro</em> fertilization (IVF), Preimplantation Genetic Diagnosis and Screening (PGD/PGS), minimally invasive surgery to repair the uterus and fallopian tubes and Reproductive Ethics and Jewish Law. </p>
<p>Dr. Lieman is the medical director of Montefiore's Institute for Reproductive Medicine and Health located in Hartsdale, NY. He also is the chairman of the Reproductive Bioethics Committee at the Albert Einstein College of Medicine and recently was appointed as a member of Yeshiva University's Program for Jewish Genetic Health as the liaison for Fertility and Reproductive Technologies.</p>
<p>Dr. Lieman has participated in clinical research in women with Polycystic Ovary Syndrome and has presented nationally on this topic. He currently is on faculty at Yeshiva University’s Center for the Jewish Future and has been actively lecturing rabbis about infertility and the intricate details of the clinical evaluation of the infertile couple and the clinical and laboratory techniques available to promote conception. He is an ATIME medical advisor and he also is working clinically and academically with the PUAH Institute in Jerusalem (Fertility and Medicine according to Halacha) and has presented collaborative data at international meetings. Dr. Lieman completed his undergraduate training at Yeshiva University. He received his medical degree from the State University of New York Health Science Center in Brooklyn (“Downstate Medical Center”) and then completed his residency training in Obstetrics and Gynecology at the Albert Einstein College of Medicine. After residency, he completed a fellowship in Reproductive Endocrinology and Infertility at the University of Medicine and Dentistry in New Jersey-New Jersey Medical School. He is board certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility.</p>
Dr. Lieman’s clinical focus is polycystic ovary syndrome (PCOS),<em> in vitro</em> fertilization (IVF), and preimplantation genetic testing (PGT). His interests also include third-party reproduction including oocyte, sperm and embryo donation, fertility preservation and minimally invasive surgery to repair the uterus and fallopian tubes.
Dr. Lieman’s research interests include PCOS and fertility treatment outcome studies. His most recent studies have used the annual Society for Assisted Reproductive Technology (SART) clinical summary report to assess various IVF treatments and results at a national level.
<p>Harry J. Lieman, MD, is the director of the Division of Reproductive Endocrinology, and Infertility, Medical Director of Montefiore’s Institute for Reproductive Medicine and Health and is the Reproductive Tissue Bank Medical Director for oocyte and sperm donation at Montefiore. He is also Professor of Obstetrics and Gynecology and Women’s Health at our Albert Einstein College of Medicine. Dr. Lieman’s clinical focus is polycystic ovary syndrome (PCOS),<em> in vitro</em> fertilization (IVF), and preimplantation genetic testing (PGT). His interests also include third-party reproduction including oocyte, sperm and embryo donation, fertility preservation and minimally invasive surgery to repair the uterus and fallopian tubes.</p><p>After receiving his Bachelor of Arts in biology from Yeshiva University in 1986, Dr. Lieman attended State University of New York- SUNY-Downstate in Brooklyn, earning his Doctor of Medicine in 1990. He began his postdoctoral education with a four-year residency in obstetrics and gynecology at Montefiore-Einstein, acting as administrative chief resident in his final year. He then pursued a fellowship in reproductive endocrinology and infertility at University of Medicine and Dentistry of New Jersey, completing the fellowship in 1996.</p><p>Dr. Lieman’s research interests include PCOS and fertility treatment outcome studies. His most recent studies have used the annual Society for Assisted Reproductive Technology (SART) clinical summary report to assess various IVF treatments and results at a national level. He has been an active contributor to his field of research, publishing journal articles, abstracts, book chapters and presenting at annual conferences and information sessions.</p><p>Dr. Lieman has been recognized several times by the American Society for Reproductive Medicine (ASRM) with STAR Awards for his many presentations at ASRM annual meetings. He has been listed in Top Doctors, New York Metro Area from 2014 through 2021. He is board certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility.</p>
Pe'er Dar
<p>Dr Dar is the director of the division of fetal medicine at Montefiore Medical Center. He was trained in obstetrics and gynecology and high risk pregnancy in Israel and completed further training in obstetrics and gynecology and clinical genetics in the USA. In addition, Dr Dar completed training in fetal surgery in Europe.</p>
<p>Dr Dar is specialized in:</p>
<p>1. Prenatal diagnosis: Prenetal screening including First trimester screening for Down syndrome; Detailed fetal anatomy scans in early and late second trimester (including early transvaginal scans); Fetal echocardiography; Neurosonography; CVS; amniocentesis; cordocentesis and placental biopsies.</p>
<p>2. In Utero procedures and surgery: Fetoscopic laser ablation for twin to twin transfusion syndrome (TTTS), RFA for TRAP syndrome, EXIT procedures, Selective fetal reductions, fetal blood transfusions, in-utero placement of vesico-amniotic shunts and thoracoamniotic shunts; </p>
<p>Dr. Dar was trained in obstetrics and gynecology and high risk pregnancy in Israel and completed further training in obstetrics and gynecology and clinical genetics in the U.S. In addition, Dr. Dar completed training in fetal surgery in Europe. Dr. Dar specializes in prenatal screening, including first trimester screening for Down syndrome; Detailed fetal anatomy scans in early and late second trimester (including early transvaginal scans); Fetal echocardiography; Neurosonography; CVS; amniocentesis; cordocentesis and placental biopsies. He also performs in utero procedures and surgery, which includes Fetoscopic laser ablation for twin to twin transfusion syndrome (TTTS), RFA for TRAP syndrome, EXIT procedures, Selective fetal reductions, fetal blood transfusions, in-utero placement of vesico-amniotic shunts and thoracoamniotic shunts.</p>
<table><tbody><tr><td><span style="font-family:'Arial',sans-serif;color:#373A3C;">Prenatal diagnosis by ultrasound of placental and fetal abnormalities</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Prenatal genetic diagnosis of fetal disorders</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Management of pregnancies complicated by all fetal abnormalities</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Management of complicated twin and other multiple pregnancies </span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Fetal therapy</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Fetal surgery including fetsocopic surgery for TTTS </span> </td></tr></tbody></table>
<p style="line-height:150%;">Fetal medicine and surgery</p><p style="line-height:150%;">Non-invasive prenatal screening (cell free DNA)</p><p style="line-height:150%;">Scar pregnancies and placenta accreta spectrum (PAS)</p><p style="line-height:150%;">Ultrasound in obstetrics and gynecology</p>
<p style="text-align: left; padding-left: 30px;">1. Mazor M, <strong>Zitzer P</strong>, Chaim W, Maymon E, Kuperman O<em>. C-reactive protein as a marker of infection in women with preterm delivery.</em> Harefuah.[Hebrew] 1993:1;124(3); 132-137.</p>
<p style="text-align: left; padding-left: 30px;">2. Maymon R, <strong>Zitzer P</strong>, Manor Y, Bukovsky I, Moroz C<em>. Placental isoferitin patterns during normal first trimester and tubal gestations</em>. Hum Reprod. 1995:10(9); 2445-2447.</p>
<p style="text-align: left; padding-left: 30px;">3. Langer R, Pansky M,<strong> Zitzer P</strong>, Bukovsky I, Golan A<em>. National Urogynecologic Survey</em>. Isr J Obstet Gynecol. 1996 :7;145-149.</p>
<p style="text-align: left; padding-left: 30px;">4. <strong>Zitzer P</strong>, Panski M, Maymon R, Langer R, Bukovski I, Golan A. <em>Pelvic splenosis as a cause of low abdominal pain- Laparoscopic management</em>. Human Reprod. 1998 :13(6);101-103.</p>
<p style="text-align: left; padding-left: 30px;">5. Arieli S, <strong>Zitzer P</strong>, Bukovsky I, Maymon R<em>. Metabolic alkalosis at term pregnancy causing fetal deterioration and distress. </em>Isr J Obstet Gynecol 1999: 10; 61-63</p>
<p style="text-align: left; padding-left: 30px;">6. <strong>Dar P</strong>, Weiner I, Sofrin O, Sachs GS, Bukovsky I, Arieli S. <em>Clinical and sonographic fetal weight estimations in active labor with ruptured membranes</em>. J Reprod Med. 2000:45(5); 390-394.</p>
<p style="text-align: left; padding-left: 30px;">7. <strong>Dar P,</strong> Gross SJ. <em>Craniofacial and neck anomalies</em>. Clin Perinatol 2000;27(4);813-837</p>
<p style="text-align: left; padding-left: 30px;">8. <strong>Dar P</strong>, Gross SJ. <em>Macrosomia-a genetic perspective</em>. Clin Obstet Gynecol. 2000:43(2); 298-308.</p>
<p style="text-align: left; padding-left: 30px;">9. <strong>Dar P</strong>, Sachs GS, Strassburger D, Bukovsky I, Arieli S. <em>Ovarian function before and after salpingectomy in artificial reproductive technology patients</em>. Hum Reprod. 2000:15(1);142-144</p>
<p style="text-align: left; padding-left: 30px;">10. <strong>Dar P,</strong> Sachs SG, Carter SM, Ferreira JC, Nitowsky HM, Gross SJ. <em>Prenatal diagnosis of Bardet-Biedl syndrome by targeted second trimester sonography. </em>Ultrasound Obstet Gynecol 2001 Apr;17(4):354-6</p>
<p style="text-align: left; padding-left: 30px;">11. Sherer DM, <strong>Dar P</strong>. <em>Prenatal ultrasonographic diagnosis of congenital umbilical hernia and associated patent omphalomesenteric duct</em>. Gynecol Obstet Invest. 2001:51(1); 66-68</p>
<p style="text-align: left; padding-left: 30px;">12<em>.</em><strong> Dar P</strong>, Strassburger D, Shaish A, Levkovitz H, Halperin R, Harats R<em>.</em><em> Reduced reproduction with increased abortion rate in transgenic mice that overexpress 15-Lipoxygenase.</em>Gynecol Obstet Invest. 2001;52(1):18-21.</p>
<p style="text-align: left; padding-left: 30px;">13. <strong>Dar P</strong>, Javed AA, Ben-Yishay M, Ferreira JC, Paterson AD, Gross SJ, Chitayat D, Morrow BE, Nitowsky HM. <em>Potential Mapping of Corneal Dermoids to Xq24-qter</em>. J Med Genetics. 2001;38(10):719-23</p>
<p style="text-align: left; padding-left: 30px;">14. Halperin R, Zehavi S, <strong>Dar P</strong>, Habler L, Hadas E, Bukovsky I, Schneider D<em>. Clinical and molecular comparison between borderline serous ovarian tumors and advanced serous papillary ovarian carcinomas</em>. Eur J Gynaecol Oncol. 2001;22(4):292-6.</p>
<p style="text-align: left; padding-left: 30px;">15. Gross SJ, Ferreira JC, Morrow BE, <strong>Dar P,</strong> Funke B, Khabele D, Merkatz I. Gene expression profile of trisomy-21 placentas – a potential approach for designing non-invasive techniques of prenatal diagnosis. Am J Obstet Gynecol. 2002. 187(2):457-62</p>
<p style="text-align: left; padding-left: 30px;">16. Vaknin Z, Halperin R, Schneider D, Teitler J, <strong>Dar P</strong>, Herman A, Herman A, Berkovitch M. <em>Hyperemesis gravidarum and nonspecific abnormal EEG findings: a preliminary </em>report. J Reprod Med. 2006 ;51(8):623-7.</p>
<p style="text-align: left; padding-left: 30px;">17. Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, <strong>Dar P</strong>, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME. First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium. <em>Comparison of Serum Markers in First-Trimester Down Syndrome Screening.</em> Obstet Gynecol. 2006 ;108(5):1192-1199.</p>
<p style="text-align: left; padding-left: 30px;">18. Dugoff L, Cuckle HS, Hobbins JC, Malone FD, Belfort MA, Nyberg DA, Comstock CH, Saade GR, Eddelman KA, <strong>Dar P,</strong> Craigo AD, Timor Tritsch IE, Carr SR, Wolfe HM, D’alton ME <sup> </sup>for the FASTER Trial Research Consortium. <em>Prediction of patient-specific risk for fetal loss using maternal characteristics and first and second trimester maternal serum Down syndrome markers.</em> Am J Obstet Gynecol. 2008 Sep;199(3):290.e1-6.</p>
<p style="text-align: left; padding-left: 30px;">19. <strong>Dar P,</strong> Karmin I, Einstein MH. <em>Arteriovenous Malformations of the Uterus: Long-Term Follow-Up.</em> Gynecol Obstet Invest. 2008 11;66(3):157-161</p>
<p style="text-align: left; padding-left: 30px;">20. Rotenberg, O., Shahabi, S., Dar, P. <em>Testosterone secreting mature ovarian teratoma causing virilization in an adolescent - Sonographic and color Doppler characteristics.</em> J Ultrasound Med. 2009 ;28(1):85-8</p>
<p style="text-align: left; padding-left: 30px;">21. D’Alton ME, Cleary-Goldman J, Lambert-Messerlian G, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, <strong>Dar P</strong>, Dugoff L, Craigo SD, Timor IE, Carr SR, Wolfe HM, Dukes K, Canick JA, Malone FD. <em>Maintaining quality assurance for nuchal translucency sonography: Lessons from the FASTER trial</em>. Ultrasound Obstet Gynecol. 2009 27;33(2):142-146</p>
<p style="text-align: left; padding-left: 30px;">22. Gebb J, <strong>Dar P</strong>. <em>Should the First Trimester Aneuploidy Screen be Maternal Age Adjusted? Screening by Absolute Risk vs. Risk Adjusted to Maternal Age.</em> Prenatal Diagnosis. 2009; 29 (3) 245-247</p>
<p style="text-align: left; padding-left: 30px;">23. Terry S., Banks E., Harris K., Duvivier R., <strong>Dar P</strong>. <em>Comparison of 3-dimensional to 2-dimensional Saline Infusion Sonohysterograms for the Evaluation of Intrauterine Abnormalities.</em> J Clinic Ultrasound. 2009 ;37(5):258-62.</p>
<p style="text-align: left; padding-left: 30px;">24. <strong>Dar P</strong>, Rosenthal J,Factor S, DubiossoR, Murthy AS <em>First trimester diagnosis of fetal epignathus with two and three-dimensional ultrasonography</em><strong>. </strong>J Ultrasound Med. 2009 Dec;28(12):1743-6</p>
<p style="text-align: left; padding-left: 30px;">25. Ram K, Goffman D, Ilagan J, <strong>Dar P</strong>. <em>First trimester diagnosis of familial split-hand split-foot malformation (SHFM)</em>. J Ultrasound Med. 2009 ;28(10):1397-400.</p>
<p style="text-align: left; padding-left: 30px;">26. <strong>Dar P</strong>, Gebb J, Reimers L, Bernstein PB, Chazotte C, Merkatz IR. <em>First trimester 3-dimensional power Doppler of the utero-placental circulation space: A potential screening method for preeclampsia. </em>AJOG. 2010 ;203(3):238.e1-7.</p>
<p style="text-align: left; padding-left: 30px;">27. <strong>Dar P</strong>, Gebb J. <em>Reply: First-trimester 3-dimensional power Doppler for the screening of preeclampsia: the analysis of a greater proportion of the uteroplacental unit might improve the accuracy of the method </em>.AJOG. 2011 Feb;204(2):e5-6.</p>
<p style="text-align: left; padding-left: 30px;">28. Gebb J, Demasio K, <strong>Dar P</strong>. <em>Prenatal sonographic diagnosis of a familial Saethre-Chotzen Syndrome. </em>J Ultrasound Med. 2011;30(3):420-2</p>
<p style="text-align: left; padding-left: 30px;">29. Gebb J, <strong>Dar P</strong>. <em>Color Doppler ultrasound of spiral artery blood flow in the prediction of preeclampsia and intrauterine growth restriction</em>. Best Prac Res Clin Obstet Gynecol. 2011. In press</p>
<p>Pe’er Dar, MD, is Director of Fetal Medicine and OBGYN Ultrasound at Montefiore and Professor of Obstetrics and Gynecology and Women’s Health at our Albert Einstein College of Medicine. Dr. Dar’s clinical focus is on the care of women who carry babies with disorders and medical conditions that may affect their lives and he leads the Fetal Medicine and Surgery Team at Montefiore. He particularly specializes in diagnosis and management of medical and structural abnormalities in the fetus and in complicated twin and triplet pregnancies. His expertise include performing detailed ultrasound examination of the fetus including fetal echocardiography (scanning of the fetal heart) and fetal neurosonography (scanning of the fetal brain) as well as performing in-utero fetal surgeries such as fetoscopic laser surgery for monochorionic twins with twin to twin transfusion syndrome, in-utero blood transfusion for fetuses with anemia and in-utero drainage and shunt procedures. Dr. Dar is also experienced in performing amniocentesis, chorionic villous sampling (CVS) and multifetal selective reduction for multiple pregnancies. </p><p>Dr. Dar completed his Doctor of Medicine from Tel-Aviv University in Tel-Aviv, Israel in 1986. He started his postgraduate education at Assaf Harofe Medical Center, Tel-Aviv University, with a residency in obstetrics and gynecology and a specialty in high-risk pregnancies from 1992 through 1998. He then came to Montefiore-Einstein, completing a two-year fellowship in medical and reproductive genetics. After spending two years as an attending-specialist in the field of prenatal diagnosis he completed in 2005 three-year residency in obstetrics and gynecology at Montefiore-Einstein. In 2007, he completed additional training in fetal surgery in world-known fetal surgery centers in France and Belgium. </p><p>Dr. Dar is very active in research and he is currently the principal investigator in many studies including international multicenter studies. His research focus is in fetal medicine and surgery, non-invasive prenatal screening and placenta accreta spectrum. He has shared his work in many peer-reviewed journals, textbook chapters, abstracts and invited presentations. He is also a reviewer for national and international journals including the <em>American Journal of Obstetrics and Gynecology, Plos one and Prenatal Diagnosis. </em></p><p>Dr. Dar is board certified in both Obstetrics and Gynecology and Clinical Genetics and is a member of several professional societies including the Society of Maternal and Fetal Medicine, International Fetal Medicine and Surgery Society and the International Society of Ultrasound in Obstetrics and Gynecology. He has been regularly listed among Castle Connolly Top Doctors for obstetrics and gynecology in the New York Metro area.</p>